The Europe Veterinary Orthopedic Implants Market would witness market growth of 4.0% CAGR during the forecast period (2022-2028).
One of the most frequent surgeries performed on pets is orthopaedic surgery. It is quite successful at restoring the joints and bones of a cat or dog to their pre-injury condition. The most frequent issues in veterinary orthopaedics relate to ligaments, joints, bones, and muscles. Although it may seem strange, most of these issues are shared by humans. Animals experience more surgical procedures following a bone fracture than do people.
Using top-notch tools is advised when performing surgery on animals. Animal procedures typically involve the use of screws, plates, pins, and wires. Over the past few years, animal sports are becoming more and more popular. These activities cause injuries, including shattered bones occasionally. Such mistakes or accidents necessitate surgery.
As a result, this factor has the potential to boost the market for veterinary orthopaedic implants. Pets are excellent stress relievers. The adoption of pet animals has increased as a result of an increase in psychological issues. This will also greatly help the market for veterinary orthopaedic implants.
In contrast to the last year, there has been a remarkable increase in the percentage of the number of dogs sold in the nation. With the adoption of animals, there will be growth in the health care requirement of the animals, which will propel the development of the veterinary orthopedic implants market in the Europe region. In Italy, it was reported that the cats and dogs were overweight by their owners. The prime reason for this is that Italian animal owners feed snacks and leftovers. Pet obesity is the most common medical issue among dogs and cats. Pets who undergo obesity are at a higher risk of long-term problems such as arthritis. Therefore, the growing occurrence of obesity might result in orthopedic implants, further increasing the development of veterinary orthopedic implants in Europe.
The Germany market dominated the Europe Veterinary Orthopedic Implants Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $9,070.9 Thousands by 2028. The UK market is anticipated to grow at a CAGR of 3.2% during (2022 - 2028). Additionally, The France market would exhibit a CAGR of 4.8% during (2022 - 2028).
Based on End User, the market is segmented into Hospital, Clinics, and Others. Based on Product Type, the market is segmented into Plates, Screws, and Others. Based on Application, the market is segmented into Cruciate Ligament Rupture, Bone Fractures, Hip Dysplasia, Elbow Dysplasia, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Vimian Group AB, Integra LifeSciences Holdings Corporation, B. Braun Melsungen AG, Johnson & Johnson, OrthoMed, Inc., Arthrex, Inc., Auxein Medical Pvt. Ltd., Ortho Max Mfg. Co. Pvt. Ltd., BLUESAO Co., Ltd., and Narang Medical Limited.
One of the most frequent surgeries performed on pets is orthopaedic surgery. It is quite successful at restoring the joints and bones of a cat or dog to their pre-injury condition. The most frequent issues in veterinary orthopaedics relate to ligaments, joints, bones, and muscles. Although it may seem strange, most of these issues are shared by humans. Animals experience more surgical procedures following a bone fracture than do people.
Using top-notch tools is advised when performing surgery on animals. Animal procedures typically involve the use of screws, plates, pins, and wires. Over the past few years, animal sports are becoming more and more popular. These activities cause injuries, including shattered bones occasionally. Such mistakes or accidents necessitate surgery.
As a result, this factor has the potential to boost the market for veterinary orthopaedic implants. Pets are excellent stress relievers. The adoption of pet animals has increased as a result of an increase in psychological issues. This will also greatly help the market for veterinary orthopaedic implants.
In contrast to the last year, there has been a remarkable increase in the percentage of the number of dogs sold in the nation. With the adoption of animals, there will be growth in the health care requirement of the animals, which will propel the development of the veterinary orthopedic implants market in the Europe region. In Italy, it was reported that the cats and dogs were overweight by their owners. The prime reason for this is that Italian animal owners feed snacks and leftovers. Pet obesity is the most common medical issue among dogs and cats. Pets who undergo obesity are at a higher risk of long-term problems such as arthritis. Therefore, the growing occurrence of obesity might result in orthopedic implants, further increasing the development of veterinary orthopedic implants in Europe.
The Germany market dominated the Europe Veterinary Orthopedic Implants Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $9,070.9 Thousands by 2028. The UK market is anticipated to grow at a CAGR of 3.2% during (2022 - 2028). Additionally, The France market would exhibit a CAGR of 4.8% during (2022 - 2028).
Based on End User, the market is segmented into Hospital, Clinics, and Others. Based on Product Type, the market is segmented into Plates, Screws, and Others. Based on Application, the market is segmented into Cruciate Ligament Rupture, Bone Fractures, Hip Dysplasia, Elbow Dysplasia, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Vimian Group AB, Integra LifeSciences Holdings Corporation, B. Braun Melsungen AG, Johnson & Johnson, OrthoMed, Inc., Arthrex, Inc., Auxein Medical Pvt. Ltd., Ortho Max Mfg. Co. Pvt. Ltd., BLUESAO Co., Ltd., and Narang Medical Limited.
Scope of the Study
Market Segments Covered in the Report:
By End User
- Hospital
- Clinics
- Others
By Product Type
- Plates
- Screws
- Others
By Application
- Cruciate Ligament Rupture
- Bone Fractures
- Hip Dysplasia
- Elbow Dysplasia
- Others
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- Vimian Group AB
- Integra LifeSciences Holdings Corporation
- B.Braun Melsungen AG
- Johnson & Johnson
- OrthoMed, Inc
- Arthrex, Inc
- Auxein Medical Pvt. Ltd
- Ortho Max Mfg. Co. Pvt. Ltd
- BLUESAO Co., Ltd
- Narang Medical Limited
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Veterinary Orthopedic Implants Market, by End User
1.4.2 Europe Veterinary Orthopedic Implants Market, by Product Type
1.4.3 Europe Veterinary Orthopedic Implants Market, by Application
1.4.4 Europe Veterinary Orthopedic Implants Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Europe Veterinary Orthopedic Implants Market by End User
3.1 Europe Hospital Market by Country
3.2 Europe Clinics Market by Country
3.3 Europe Others Market by Country
Chapter 4. Europe Veterinary Orthopedic Implants Market by Product Type
4.1 Europe Plates Market by Country
4.2 Europe Screws Market by Country
4.3 Europe Others Market by Country
Chapter 5. Europe Veterinary Orthopedic Implants Market by Application
5.1 Europe Cruciate Ligament Rupture Market by Country
5.2 Europe Bone Fractures Market by Country
5.3 Europe Hip Dysplasia Market by Country
5.4 Europe Elbow Dysplasia Market by Country
5.5 Europe Others Market by Country
Chapter 6. Europe Veterinary Orthopedic Implants Market by Country
6.1 Germany Veterinary Orthopedic Implants Market
6.1.1 Germany Veterinary Orthopedic Implants Market by End User
6.1.2 Germany Veterinary Orthopedic Implants Market by Product Type
6.1.3 Germany Veterinary Orthopedic Implants Market by Application
6.2 UK Veterinary Orthopedic Implants Market
6.2.1 UK Veterinary Orthopedic Implants Market by End User
6.2.2 UK Veterinary Orthopedic Implants Market by Product Type
6.2.3 UK Veterinary Orthopedic Implants Market by Application
6.3 France Veterinary Orthopedic Implants Market
6.3.1 France Veterinary Orthopedic Implants Market by End User
6.3.2 France Veterinary Orthopedic Implants Market by Product Type
6.3.3 France Veterinary Orthopedic Implants Market by Application
6.4 Russia Veterinary Orthopedic Implants Market
6.4.1 Russia Veterinary Orthopedic Implants Market by End User
6.4.2 Russia Veterinary Orthopedic Implants Market by Product Type
6.4.3 Russia Veterinary Orthopedic Implants Market by Application
6.5 Spain Veterinary Orthopedic Implants Market
6.5.1 Spain Veterinary Orthopedic Implants Market by End User
6.5.2 Spain Veterinary Orthopedic Implants Market by Product Type
6.5.3 Spain Veterinary Orthopedic Implants Market by Application
6.6 Italy Veterinary Orthopedic Implants Market
6.6.1 Italy Veterinary Orthopedic Implants Market by End User
6.6.2 Italy Veterinary Orthopedic Implants Market by Product Type
6.6.3 Italy Veterinary Orthopedic Implants Market by Application
6.7 Rest of Europe Veterinary Orthopedic Implants Market
6.7.1 Rest of Europe Veterinary Orthopedic Implants Market by End User
6.7.2 Rest of Europe Veterinary Orthopedic Implants Market by Product Type
6.7.3 Rest of Europe Veterinary Orthopedic Implants Market by Application
Chapter 7. Company Profiles
7.1 Vimian Group AB
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Recent strategies and developments:
7.1.4.1 Acquisition and Mergers:
7.1.4.2 Geographical Expansions:
7.2 Integra LifeSciences Holdings Corporation
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.2.5 Recent strategies and developments:
7.2.5.1 Acquisition and Mergers:
7.3 B. Braun Melsungen AG
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expenses
7.4 Johnson & Johnson
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental &Regional Analysis
7.4.4 Research & Development Expenses
7.5 OrthoMed, Inc.
7.5.1 Company Overview
7.6 Arthrex, Inc.
7.6.1 Company Overview
7.7 Auxein Medical Pvt. Ltd.
7.7.1 Company Overview
7.8 Ortho Max Mfg. Co. Pvt. Ltd.
7.8.1 Company Overview
7.9 BLUESAO Co., Ltd.
7.9.1 Company Overview
7.10. Narang Medical Limited
7.10.1 Company Overview
Companies Mentioned
- Vimian Group AB
- Integra LifeSciences Holdings Corporation
- B. Braun Melsungen AG
- Johnson & Johnson
- OrthoMed, Inc.
- Arthrex, Inc.
- Auxein Medical Pvt. Ltd.
- Ortho Max Mfg. Co. Pvt. Ltd.
- BLUESAO Co., Ltd.
- Narang Medical Limited
Methodology
LOADING...
